Posts Tagged ‘Vaccine’

Cancer vaccine being tested for mesothelioma treatment gains patent in Europe, trials continue

16 Nov 2016 by under Research/Treatment

research test tubes 100x100 Cancer vaccine being tested for mesothelioma treatment gains patent in Europe, trials continueA cancer being clinically tested in mesothelioma patients continues to gain traction.

Earlier this month, Targovax, the immune-oncology company developing the vaccine, acquired a European patent for its new ONCOS-102 product after receiving a patent for the cancer vaccine in May from the United States.

The vaccine, now in the beginning trial stages, generates viruses, called oncolytic viruses, that specifically target and infect cancer cells and function as immune activators. A previous Phase I trial reported ONCOS-102 treatment induced tumor-specific immune activation both at a systemic and lesional level in tumors of late stage cancer patients. (more…)


Pleural mesothelioma WT1 vaccine is renamed “galinpepimut-S”

8 Apr 2016 by under Research/Treatment

research test tubes 100x100 Pleural mesothelioma WT1 vaccine is renamed galinpepimut SA clinical-stage immunotherapy vaccine to be used for the treatment of malignant pleural , as well as a wide range of hematologic cancers and solid tumors, has been dubbed “” by the United States Adopted Named Council of the American Medical Association. (more…)